MSB 3.21% $1.13 mesoblast limited

Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients, page-92

  1. 15,643 Posts.
    lightbulb Created with Sketch. 5711
    Given the FDA (generally) isn't open on the weekends (although it might be atm?) I would assume this approval came through late on Friday arvo so some lucky patients may already be receiving doses ?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.